GAMMA Investing LLC Has $1.27 Million Stock Position in CVS Health Corporation (NYSE:CVS)

GAMMA Investing LLC increased its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 198.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,669 shares of the pharmacy operator's stock after buying an additional 12,415 shares during the period. GAMMA Investing LLC's holdings in CVS Health were worth $1,265,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Yousif Capital Management LLC increased its stake in shares of CVS Health by 2.8% in the 1st quarter. Yousif Capital Management LLC now owns 231,834 shares of the pharmacy operator's stock valued at $15,707,000 after acquiring an additional 6,207 shares during the last quarter. Pallas Capital Advisors LLC increased its stake in shares of CVS Health by 197.0% in the 1st quarter. Pallas Capital Advisors LLC now owns 30,877 shares of the pharmacy operator's stock valued at $2,092,000 after acquiring an additional 20,480 shares during the last quarter. WFA Asset Management Corp increased its stake in shares of CVS Health by 47.4% in the 1st quarter. WFA Asset Management Corp now owns 1,950 shares of the pharmacy operator's stock valued at $132,000 after acquiring an additional 627 shares during the last quarter. Cetera Trust Company N.A increased its stake in shares of CVS Health by 45.8% in the 1st quarter. Cetera Trust Company N.A now owns 11,543 shares of the pharmacy operator's stock valued at $782,000 after acquiring an additional 3,625 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in shares of CVS Health by 27.2% in the 1st quarter. Farther Finance Advisors LLC now owns 16,278 shares of the pharmacy operator's stock valued at $1,107,000 after acquiring an additional 3,481 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Truist Financial increased their target price on CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Mizuho increased their target price on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Royal Bank Of Canada increased their target price on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Cowen reissued a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Finally, Wells Fargo & Company reissued an "overweight" rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

Insiders Place Their Bets

In other news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director now owns 12,007 shares in the company, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.22% of the company's stock.

CVS Health Stock Performance

NYSE:CVS opened at $68.50 on Monday. The stock has a market cap of $86.66 billion, a P/E ratio of 16.35, a PEG ratio of 0.98 and a beta of 0.56. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The business's 50-day moving average price is $64.86 and its two-hundred day moving average price is $60.93. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same period last year, the company earned $1.31 EPS. The business's quarterly revenue was up 7.0% compared to the same quarter last year. As a group, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.